$1.00
Today
as of Sep 4, 16:53 ET
Last 30 days
Recent Press Releases & News
Revelation Biosciences Selects Avance Clinical as CRO for Phase 2/3 TITAN Study
REVB Approaching a Critical Inflection Point
Revelation Biosciences, Inc. Announces Financial Results for the Three and Six Months Ended June 30, 2026
Overview
52-week range
$0.88
$12
1% of range
Avg surprise (last 3)
-41.2%
Avg reaction (last 2)
+3.5%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.87 | — | — | — | — | financials |
| Thu May 7, 2026 | Mar/2026 | $-2.71 | $-1.15 | -135.7% | -28.4% | 0.0% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-1.77 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $-7.01 | $-4.46 | -57.2% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $-2.11 | $-6.88 | +69.3% | — | +6.9% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-40.15 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-246.27 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-39.37 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-9.94 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-5.83 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $37.07 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-4M | $-3M | — | $-2M | $-2M | $-2M | — | $-2M |
| Net income | $-3M | $-3M | — | $-2M | $-2M | $-2M | — | $-2M |
| EPS (diluted) | $-0.87 | $-2.71 | — | $-1.77 | $-28.04 | $-25.34 | — | $-40.15 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $11M | $14M | $11M | $13M | $5M | $4M | $6M | $7M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $12M | $14M | $11M | $13M | $5M | $4M | $7M | $7M |
| Total assets | $12M | $15M | $12M | $13M | $5M | $4M | $7M | $7M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $2M | $2M | $3M | $2M | $2M | $1M | $2M | $4M |
| Total equity | $10M | $13M | $9M | $11M | $4M | $3M | $5M | $3M |
Implied volatility — last 90 days
No IV snapshots yet for REVB.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.